Position in LKFT
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$659
+$209 QoQ
Shares Held
22
+46.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 78 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IMA Advisory Services, Inc. holds $6,491,044 across 19 Biotechnology names. LKFT ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
90,439 | $4,920,785 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,079 | $1,296,339 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
3,850 | $150,188 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
1,037 | $82,223 | |
| 5 | INCY |
Incyte Corp
|
62 | $7,028 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
31 | $5,805 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
15 | $5,575 | |
| 8 | MRNA |
Moderna, Inc.
|
70 | $4,902 |
All Filings in LKFT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $659 | 22 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $450 | 15 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $490 | 15 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||